BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6218577)

  • 1. Moxalactam therapy vs. standard antimicrobial therapy for selected serious infections.
    Oblinger MJ; Bowers JT; Sande MA; Mandell GL
    Rev Infect Dis; 1982; 4 Suppl():S639-49. PubMed ID: 6218577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxalactam: clinical summary of efficacy and safety.
    Kammer RB
    Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterococcal infections in patients treated with moxalactam.
    Moellering RC
    Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxalactam in the treatment of pediatric infections.
    Yogev R; Schreiber M; Gardner S; Shulman ST
    Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
    Abbruzzese JL; Rocco LE; Laskin OL; Skubitz KM; McGaughey MD; Lipsky JJ
    Am J Med; 1983 Apr; 74(4):694-9. PubMed ID: 6220603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
    Trager GM; Panwalker AP; Malow JB; Porembski PE; Ramirez CA; Zar FA
    Chemotherapy; 1981; 27(4):287-95. PubMed ID: 6454542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 9. Moxalactam in the therapy of serious infections.
    Marier RL; Faro S; Sanders CV; Williams W; Derks F; Janney A; Aldridge K
    Antimicrob Agents Chemother; 1982 Apr; 21(4):650-4. PubMed ID: 6211140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of moxalactam.
    Livingston WK; Elliott AM; Dismukes WE; Avent CK; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jul; 20(1):88-97. PubMed ID: 6456688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intraabdominal infection with moxalactam.
    Murphy TF; Barza M
    Rev Infect Dis; 1982; 4 Suppl():S670-5. PubMed ID: 6218581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxalactam therapy for bacterial pneumonia.
    Perlino CA
    Rev Infect Dis; 1982; 4 Suppl():S617-22. PubMed ID: 6218574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of moxalactam in complicated urinary tract infections.
    Kumazawa J
    Rev Infect Dis; 1982; 4 Suppl():S692-5. PubMed ID: 6218585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of moxalactam].
    Acar JF
    Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of lower respiratory tract infections with moxalactam.
    Lentino JR; Rytel MW; Moore E
    Antimicrob Agents Chemother; 1981 May; 19(5):801-6. PubMed ID: 6457557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
    Carbon C
    Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.